These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 8689657)
1. Negative dromotropic effects of class I antiarrhythmic drugs in anisotropic ventricular muscle. Iida M; Kodama I; Toyama J Cardiovasc Res; 1996 Apr; 31(4):640-50. PubMed ID: 8689657 [TBL] [Abstract][Full Text] [Related]
2. Open and inactivated sodium channel block by class-I antiarrhythmic drugs. Kodama I; Toyama J; Yamada K Jpn Heart J; 1986 Nov; 27 Suppl 1():83-9. PubMed ID: 2434686 [TBL] [Abstract][Full Text] [Related]
3. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of quinidine, flecainide, and cibenzoline on anisotropic conduction in the isolated porcine heart. Lacroix D; Delfaut P; Adamantidis M; Cardinal R; Klug D; Kacet S; Dupuis B J Cardiovasc Electrophysiol; 1998 Jan; 9(1):55-69. PubMed ID: 9475578 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs. Nawada T; Tanaka Y; Hirai S; Hisatome I; Hasegawa J; Kotake H; Mashiba H Int J Clin Pharmacol Ther; 1994 Jul; 32(7):347-55. PubMed ID: 7952796 [TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic effects of TYB-3823, a new antiarrhythmic agent, on isolated guinea pig ventricular muscles. Kodama I; Morimoto M; Toyama J; Shibata S J Cardiovasc Pharmacol; 1989 Apr; 13(4):616-23. PubMed ID: 2471000 [TBL] [Abstract][Full Text] [Related]
7. Frequency- and voltage-dependent effects of recainam on the upstroke velocity of action potential in rabbit ventricular muscle. Kamiya K; Takikawa R; Singh BN J Cardiovasc Pharmacol; 1989 Apr; 13(4):630-7. PubMed ID: 2471002 [TBL] [Abstract][Full Text] [Related]
8. Modulation of flecainide's cardiac sodium channel blocking actions by extracellular sodium: a possible cellular mechanism for the action of sodium salts in flecainide cardiotoxicity. Ranger S; Sheldon R; Fermini B; Nattel S J Pharmacol Exp Ther; 1993 Mar; 264(3):1160-7. PubMed ID: 8383739 [TBL] [Abstract][Full Text] [Related]
9. Combined application of class I antiarrhythmic drugs causes "additive", "reductive", or "synergistic" sodium channel block in cardiac muscles. Kawamura T; Kodama I; Toyama J; Hayashi H; Saito H; Yamada K Cardiovasc Res; 1990 Nov; 24(11):925-31. PubMed ID: 2176934 [TBL] [Abstract][Full Text] [Related]
10. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization. Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812 [TBL] [Abstract][Full Text] [Related]
11. Competitive inhibition of cardiac sodium channels by aprindine and lidocaine studied using a maximum upstroke velocity of action potential in guinea pig ventricular muscles. Kodama I; Toyama J; Yamada K J Pharmacol Exp Ther; 1987 Jun; 241(3):1065-71. PubMed ID: 2439681 [TBL] [Abstract][Full Text] [Related]
12. Electrophysiological effects of sodium channel blockers on guinea pig left atrium. Shirayama T; Inoue D; Inoue M; Tatsumi T; Yamahara Y; Asayama J; Katsume H; Nakagawa M J Pharmacol Exp Ther; 1991 Nov; 259(2):884-93. PubMed ID: 1658312 [TBL] [Abstract][Full Text] [Related]
13. A model study of time- and voltage-dependent effects of class I antiarrhythmic drugs in guinea-pig papillary muscles as related to external potassium concentration. Hamamoto T; Kojima M; Matsuzaki M; Kusukawa R; Ban T Arzneimittelforschung; 1994 Aug; 44(8):929-37. PubMed ID: 7945535 [TBL] [Abstract][Full Text] [Related]
14. [New aspects of the molecular effect of anti-arrhythmia agents]. Honerjäger P Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907 [TBL] [Abstract][Full Text] [Related]
15. Basic cardiac electrophysiology and mechanisms of antiarrhythmic agents. Perry RS; Illsley SS Am J Hosp Pharm; 1986 Apr; 43(4):957-74. PubMed ID: 2871752 [TBL] [Abstract][Full Text] [Related]
16. Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockade. Honerjäger P; Loibl E; Steidl I; Schönsteiner G; Ulm K Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):184-95. PubMed ID: 2422563 [TBL] [Abstract][Full Text] [Related]
17. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo. Costard-Jäckle A; Franz MR J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468 [TBL] [Abstract][Full Text] [Related]
18. Effects of halothane and enflurane on conduction velocity and maximum rate of rise of action potential upstroke in guinea pig papillary muscles. Ozaki S; Nakaya H; Gotoh Y; Azuma M; Kemmotsu O; Kanno M Anesth Analg; 1989 Mar; 68(3):219-25. PubMed ID: 2919756 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue. Wang Z; Fermini B; Nattel S J Pharmacol Exp Ther; 1993 Nov; 267(2):575-81. PubMed ID: 8246130 [TBL] [Abstract][Full Text] [Related]
20. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study. Cimponeriu A; Starmer CF; Bezerianos A IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]